Both in Pharmaceuticals
Braveheart Bio vs Schrodinger
Over the past year BRVE returned −21.0% and SDGR returned +37.7%; their daily moves had a correlation of 0.16.
BRVE −21.0% SDGR +37.7%Growth of $1, one year, split-adjusted
| Metric | BRVE | SDGR |
|---|---|---|
| Price | $21.04 | $26.19 |
| Market cap | $1.89B | $1.96B |
| Today | −2.19% | −3.50% |
| 1 month | −1.1% | −13.6% |
| 6 months | — | +103.0% |
| Year to date | — | +46.5% |
| 1 year | — | +28.0% |
| Revenue growth (YoY) | — | +7.5% |
| Gross margin | — | 55.1% |
| Net margin | — | 10.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 7.6× |
| Net cash | — | $413.7M |
| Dividend yield | — | — |
| Volatility (60d) | — | 94.1% |
| Short % of float | 10.9% | 19.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).